LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the Company received a shareholders' requisition dated June 14, 2024, issued by certain shareholders of the Company holding shares which carry in aggregate not less than 10% of all votes attaching to a
Viewing insider transactions for LakeShore Biopharma Co., Ltd's ( NASDAQ:LSB ) over the last year, we see that insiders...
LakeShore Biopharma Co., Ltd ( NASDAQ:LSB ) is possibly approaching a major achievement in its business, so we would...